{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T06:19:34Z","timestamp":1788848374500,"version":"build-2803163510"},"reference-count":60,"publisher":"Public Library of Science (PLoS)","issue":"4","license":[{"start":{"date-parts":[[2012,4,19]],"date-time":"2012-04-19T00:00:00Z","timestamp":1334793600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0034947","type":"journal-article","created":{"date-parts":[[2012,4,19]],"date-time":"2012-04-19T17:03:23Z","timestamp":1334855003000},"page":"e34947","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":64,"title":["Anti-HIV-1 Activity of a New Scorpion Venom Peptide Derivative Kn2-7"],"prefix":"10.1371","volume":"7","author":[{"given":"Yaoqing","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luyang","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maohua","family":"Zhong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chen","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiaoli","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingyi","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dihan","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benxia","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fang","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuan","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yaoming","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenxin","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deying","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhijian","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huimin","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2012,4,19]]},"reference":[{"key":"ref1","volume":"23","author":"UNAIDS","year":"2010"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1517\/14728214.12.1.23","article-title":"Problems and emerging approaches in HIV\/AIDS vaccine development.","volume":"12","author":"F Titti","year":"2007","journal-title":"Expert Opin Emerg Drugs"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"1881","DOI":"10.1016\/S0140-6736(08)61591-3","article-title":"Efficacy assessment of a cell-mediated immunity HIV-1 vaccine (the Step Study): a double-blind, randomised, placebo-controlled, test-of-concept trial.","volume":"372","author":"SP Buchbinder","year":"2008","journal-title":"Lancet"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"2209","DOI":"10.1056\/NEJMoa0908492","article-title":"Vaccination with ALVAC and AIDSVAX to prevent HIV-1 infection in Thailand.","volume":"361","author":"S Rerks-Ngarm","year":"2009","journal-title":"N Engl J Med"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1038\/312763a0","article-title":"The CD4 (T4) antigen is an essential component of the receptor for the AIDS retrovirus.","volume":"312","author":"AG Dalgleish","year":"1984","journal-title":"Nature"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1038\/381661a0","article-title":"Identification of a major co-receptor for primary isolates of HIV-1.","volume":"381","author":"H Deng","year":"1996","journal-title":"Nature"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1016\/S0092-8674(00)81314-8","article-title":"A dual-tropic primary HIV-1 isolate that uses fusin and the beta-chemokine receptors CKR-5, CKR-3, and CKR-2b as fusion cofactors.","volume":"85","author":"BJ Doranz","year":"1996","journal-title":"Cell"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1126\/science.272.5263.872","article-title":"HIV-1 entry cofactor: functional cDNA cloning of a seven-transmembrane, G protein-coupled receptor.","volume":"272","author":"Y Feng","year":"1996","journal-title":"Science"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1186\/1471-2334-2-27","article-title":"Anti-HIV-1 activity of anionic polymers: a comparative study of candidate microbicides.","volume":"2","author":"AR Neurath","year":"2002","journal-title":"BMC Infect Dis"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.antiviral.2011.03.186","article-title":"Virucidal activity of the dendrimer microbicide SPL7013 against HIV-1.","volume":"90","author":"S Telwatte","year":"2011","journal-title":"Antiviral Research"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"4868","DOI":"10.1128\/JVI.74.10.4868-4876.2000","article-title":"Variable sensitivity of CCR5-tropic human immunodeficiency virus type 1 isolates to inhibition by RANTES analogs.","volume":"74","author":"VS Torre","year":"2000","journal-title":"J Virol"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1016\/S0140-6736(10)61086-0","article-title":"PRO2000 vaginal gel for prevention of HIV-1 infection (Microbicides Development Programme 301): a phase 3, randomised, double-blind, parallel-group trial.","volume":"376","author":"S McCormack","year":"2010","journal-title":"Lancet"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1095\/biolreprod54.1.173","article-title":"Sulfated polysaccharides inhibit lymphocyte-to-epithelial transmission of human immunodeficiency virus-1.","volume":"54","author":"R Pearce-Pratt","year":"1996","journal-title":"Biol Reprod"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/j.antiviral.2007.03.008","article-title":"In vitro anti-HIV and -HSV activity and safety of sodium rutin sulfate as a microbicide candidate.","volume":"75","author":"J Tao","year":"2007","journal-title":"Antiviral Res"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.antiviral.2006.07.008","article-title":"Parameters of inhibition of HIV-1 infection by small anionic microbicides.","volume":"73","author":"AN Vzorov","year":"2007","journal-title":"Antiviral Res"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1089\/aid.2008.0043","article-title":"Enhancement of HIV infection by cellulose sulfate.","volume":"24","author":"W Tao","year":"2008","journal-title":"AIDS Res Hum Retroviruses"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1034\/j.1600-065X.2000.917301.x","article-title":"Innate immunity and the normal microflora.","volume":"173","author":"HG Boman","year":"2000","journal-title":"Immunol Rev"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/S0167-7799(97)01156-6","article-title":"Cationic peptides: a new source of antibiotics.","volume":"16","author":"RE Hancock","year":"1998","journal-title":"Trends Biotechnol"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"1148","DOI":"10.1093\/bioinformatics\/btm068","article-title":"AMPer: a database and an automated discovery tool for antimicrobial peptides.","volume":"23","author":"CD Fjell","year":"2007","journal-title":"Bioinformatics"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1128\/CMR.00056-05","article-title":"Peptide antimicrobial agents.","volume":"19","author":"H Jenssen","year":"2006","journal-title":"Clin Microbiol Rev"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1002\/jlb.58.2.128","article-title":"Defensins and other endogenous peptide antibiotics of vertebrates.","volume":"58","author":"E Martin","year":"1995","journal-title":"J Leukoc Biol"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"D590","DOI":"10.1093\/nar\/gkh025","article-title":"APD: the Antimicrobial Peptide Database.","volume":"32","author":"Z Wang","year":"2004","journal-title":"Nucleic Acids Res"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1038\/415389a","article-title":"Antimicrobial peptides of multicellular organisms.","volume":"415","author":"M Zasloff","year":"2002","journal-title":"Nature"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1186\/1471-2164-10-290","article-title":"Transcriptome analysis of the venom gland of the scorpion Scorpiops jendeki: implication for the evolution of the scorpion venom arsenal.","volume":"10","author":"Y Ma","year":"2009","journal-title":"BMC Genomics"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1016\/S0300-9084(00)01167-6","article-title":"Peptides and genes coding for scorpion toxins that affect ion-channels.","volume":"82","author":"LD Possani","year":"2000","journal-title":"Biochimie"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1016\/j.toxicon.2005.11.013","article-title":"Genetic mechanisms of scorpion venom peptide diversification.","volume":"47","author":"C Zhijian","year":"2006","journal-title":"Toxicon"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"5023","DOI":"10.1046\/j.1432-1327.2000.01556.x","article-title":"Hadrurin, a new antimicrobial peptide from the venom of the scorpion Hadrurus aztecus.","volume":"267","author":"A Torres-Larios","year":"2000","journal-title":"Eur J Biochem"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/S0014-5793(00)01384-3","article-title":"Scorpine, an anti-malaria and anti-bacterial agent purified from scorpion venom.","volume":"471","author":"R Conde","year":"2000","journal-title":"FEBS Lett"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"4799","DOI":"10.1046\/j.1432-1033.2002.03177.x","article-title":"Antibacterial and antifungal properties of alpha-helical, cationic peptides in the venom of scorpions from southern Africa.","volume":"269","author":"L Moerman","year":"2002","journal-title":"Eur J Biochem"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1006\/bbrc.2001.5472","article-title":"IsCT, a novel cytotoxic linear peptide from scorpion Opisthacanthus madagascariensis.","volume":"286","author":"L Dai","year":"2001","journal-title":"Biochem Biophys Res Commun"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"3967","DOI":"10.1128\/AAC.00542-08","article-title":"Mucroporin, the first cationic host defense peptide from the venom of Lychas mucronatus.","volume":"52","author":"C Dai","year":"2008","journal-title":"Antimicrob Agents Chemother"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"3472","DOI":"10.1128\/AAC.01436-08","article-title":"Imcroporin, a new cationic antimicrobial peptide from the venom of the scorpion Isometrus maculates.","volume":"53","author":"Z Zhao","year":"2009","journal-title":"Antimicrob Agents Chemother"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1016\/j.ijantimicag.2003.07.022","article-title":"Antiviral activity of antimicrobial cationic peptides against Junin virus and herpes simplex virus.","volume":"23","author":"VC Albiol Matanic","year":"2004","journal-title":"Int J Antimicrob Agents"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"14318","DOI":"10.1128\/JVI.79.22.14318-14329.2005","article-title":"Human beta-defensins suppress human immunodeficiency virus infection: potential role in mucosal protection.","volume":"79","author":"L Sun","year":"2005","journal-title":"J Virol"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1590\/S0074-02762007005000028","article-title":"In vitro antiviral activity of antimicrobial peptides against herpes simplex virus 1, adenovirus, and rotavirus.","volume":"102","author":"MC Carriel-Gomes","year":"2007","journal-title":"Mem Inst Oswaldo Cruz"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.peptides.2010.10.008","article-title":"A new natural alpha-helical peptide from the venom of the scorpion Heterometrus petersii kills HCV.","volume":"32","author":"R Yan","year":"2011","journal-title":"Peptides"},{"issue":"3","key":"ref37","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1016\/j.antiviral.2010.03.012","article-title":"Antiviral activity of selected antimicrobial peptides against vaccinia virus.","volume":"86","author":"KV Mohan","year":"2010","journal-title":"Antiviral Res"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"1518","DOI":"10.1016\/j.peptides.2011.05.015","article-title":"Virucidal activity of a scorpion venom peptide variant mucroporin-M1 against measles, SARS-CoV and influenza H5N1 viruses.","volume":"32","author":"Q Li","year":"2011","journal-title":"Peptides"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.peptides.2003.12.003","article-title":"Identification and functional characterization of novel scorpion venom peptides with no disulfide bridge from Buthus martensii Karsch.","volume":"25","author":"XC Zeng","year":"2004","journal-title":"Peptides"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1006\/jmbi.1993.1413","article-title":"Prediction of protein secondary structure at better than 70% accuracy.","volume":"232","author":"B Rost","year":"1993","journal-title":"Journal of Molecular Biology"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"207","DOI":"10.3727\/095535491820873191","article-title":"Use of an aqueous soluble tetrazolium\/formazan assay for cell growth assays in culture.","volume":"3","author":"A Cory","year":"1991","journal-title":"Cancer communications"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.virol.2007.01.015","article-title":"Cross-reactive HIV-1 neutralizing monoclonal antibodies selected by screening of an immune human phage library against an envelope glycoprotein (gp140) isolated from a patient (R2) with broadly HIV-1 neutralizing antibodies.","volume":"363","author":"V Choudhry","year":"2007","journal-title":"Virology"},{"key":"ref43","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/S0092-8674(00)80110-5","article-title":"Homozygous defect in HIV-1 coreceptor accounts for resistance of some multiply-exposed individuals to HIV-1 infection.","volume":"86","author":"R Liu","year":"1996","journal-title":"Cell"},{"issue":"2","key":"ref44","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1002\/rmv.684","article-title":"HIV sexual transmission and microbicides.","volume":"21","author":"KK Arien","year":"2011","journal-title":"Rev Med Virol"},{"key":"ref45","doi-asserted-by":"crossref","first-page":"10108","DOI":"10.1128\/JVI.79.16.10108-10125.2005","article-title":"Human Immunodeficiency Virus Type 1 env Clones from Acute and Early Subtype B Infections for Standardized Assessments of Vaccine-Elicited Neutralizing Antibodies.","volume":"79","author":"M Li","year":"2005","journal-title":"Journal of Virology"},{"key":"ref46","doi-asserted-by":"crossref","first-page":"6900","DOI":"10.4049\/jimmunol.176.11.6900","article-title":"HIV-1 adapts to a retrocyclin with cationic amino acid substitutions that reduce fusion efficiency of gp41.","volume":"176","author":"AL Cole","year":"2006","journal-title":"The Journal of Immunology"},{"key":"ref47","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1038\/nrmicro1098","article-title":"Antimicrobial peptides: pore formers or metabolic inhibitors in bacteria?","volume":"3","author":"KA Brogden","year":"2005","journal-title":"Nat Rev Microbiol"},{"key":"ref48","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1002\/(SICI)1097-0282(1998)47:6<451::AID-BIP4>3.0.CO;2-F","article-title":"Mode of action of linear amphipathic alpha-helical antimicrobial peptides.","volume":"47","author":"Z Oren","year":"1998","journal-title":"Biopolymers"},{"key":"ref49","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1017\/S0033583500000123","article-title":"Electrically gated ionic channels in lipid bilayers.","volume":"10","author":"G Ehrenstein","year":"1977","journal-title":"Quarterly reviews of biophysics"},{"key":"ref50","doi-asserted-by":"crossref","first-page":"1896","DOI":"10.1128\/AAC.46.6.1896-1905.2002","article-title":"Emergence of resistant human immunodeficiency virus type 1 in patients receiving fusion inhibitor (T-20) monotherapy.","volume":"46","author":"X Wei","year":"2002","journal-title":"Antimicrob Agents Chemother"},{"key":"ref51","doi-asserted-by":"crossref","first-page":"2855","DOI":"10.1128\/JVI.72.4.2855-2864.1998","article-title":"Effects of CCR5 and CD4 cell surface concentrations on infections by macrophagetropic isolates of human immunodeficiency virus type 1.","volume":"72","author":"EJ Platt","year":"1998","journal-title":"J Virol"},{"key":"ref52","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1038\/nature01470","article-title":"Antibody neutralization and escape by HIV-1.","volume":"422","author":"X Wei","year":"2003","journal-title":"Nature"},{"key":"ref53","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1128\/JVI.59.2.284-291.1986","article-title":"Production of acquired immunodeficiency syndrome-associated retrovirus in human and nonhuman cells transfected with an infectious molecular clone.","volume":"59","author":"A Adachi","year":"1986","journal-title":"J Virol"},{"key":"ref54","first-page":"327","article-title":"The treatment and prevention of chronic otorrhoea in the Northland health district.","volume":"86","author":"MA Hamilton","year":"1977","journal-title":"N Z Med J"},{"key":"ref55","doi-asserted-by":"crossref","first-page":"5765","DOI":"10.1128\/JVI.65.11.5765-5773.1991","article-title":"Recombinational analysis of a natural noncytopathic human immunodeficiency virus type 1 (HIV-1) isolate: role of the vif gene in HIV-1 infection kinetics and cytopathicity.","volume":"65","author":"K Sakai","year":"1991","journal-title":"J Virol"},{"key":"ref56","doi-asserted-by":"crossref","DOI":"10.1002\/0471142735.im1211s64","article-title":"Evaluating neutralizing antibodies against HIV, SIV, and SHIV in luciferase reporter gene assays.","volume":"11","author":"DC Montefiori","year":"2005","journal-title":"Curr Protoc Immunol Chapter 12: Unit 12"},{"key":"ref57","doi-asserted-by":"crossref","first-page":"e24296","DOI":"10.1371\/journal.pone.0024296","article-title":"Unpolarized release of vaccinia virus and HIV antigen by colchicine treatment enhances intranasal HIV antigen expression and mucosal humoral responses.","volume":"6","author":"Y Zhang","year":"2011","journal-title":"PLoS ONE"},{"key":"ref58","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.ab.2008.03.035","article-title":"Determining kinetics and affinities of protein interactions using a parallel real-time label-free biosensor, the Octet.","volume":"377","author":"Y Abdiche","year":"2008","journal-title":"Analytical Biochemistry"},{"key":"ref59","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.pep.2008.04.009","article-title":"A rapid method for determining dynamic binding capacity of resins for the purification of proteins.","volume":"60","author":"T Do","year":"2008","journal-title":"Protein Expr Purif"},{"key":"ref60","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1093\/oxfordjournals.aje.a118408","article-title":"A simple method of estimating fifty per cent endpoints.","volume":"27","author":"LJ Reed","year":"1938","journal-title":"American Journal of Epidemiology"}],"container-title":["PLoS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0034947","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,7,6]],"date-time":"2020-07-06T01:15:34Z","timestamp":1593998134000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0034947"}},"subtitle":[],"editor":[{"given":"Alexander M.","family":"Cole","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2012,4,19]]},"references-count":60,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2012,4,19]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0034947","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,4,19]]}}}